glp-1 compounding crackdown news october 2025 FDA Puts Pressure on Compounders, Telehealth Providers New project announcement: HHS‑OIG is

Heres where things get interesting

M., Greenway, F

Special populations and considerations Certain groups face unique considerations when switching from tirzepatide to semaglutide

10.1053/j.gastro.2024.04.029 [DOI] [PMC free article] [PubMed] [Google Scholar] Wei S., Wang L., Evans P

This evolving landscape is further complicated by the body positivity movement, which challenges traditional pathologizing frameworks and advocates for a broader appreciation of body diversity and health beyond BMI

How to Combat Nausea on GLP-1 Medications (Ozempic, Wegovy, Zepbound, Mounjaro) Nausea is a common side effect of GLP-1 weight loss medications like Ozempic, Wegovy, Zepbound and Mounjaro